Preliminary analysis of the effect of different administration routes of tranexamic acid on blood loss after total hip arthroplasty for female femur neck fractures.
10.3969/j.issn.1003-0034.2018.12.002
- Author:
Guo-Gang LUO
1
,
2
;
Zhong-Qin LIN
3
;
Hai-Feng XIE
3
;
Jian-Chuan YAO
3
;
Hong-Zhen ZHANG
3
Author Information
1. Department of Joint Surgery, Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine, Wenzhou 325000, Zhejiang, China
2. owen_509@163.com.
3. Department of Joint Surgery, Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine, Wenzhou 325000, Zhejiang, China.
- Publication Type:Journal Article
- Keywords:
Arthroplasty, replacement, hip;
Blood loss, surgical;
Femoral neck fracture;
Tranexamic acid
- MeSH:
Aged;
Aged, 80 and over;
Antifibrinolytic Agents;
Arthroplasty, Replacement, Hip;
Arthroplasty, Replacement, Knee;
Blood Loss, Surgical;
Blood Transfusion;
Female;
Femoral Neck Fractures;
Humans;
Postoperative Hemorrhage;
Tranexamic Acid
- From:
China Journal of Orthopaedics and Traumatology
2018;31(12):1086-1090
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To study curative effect of different administration routes of tranexamic acid (TXA) on blood loss of elderly female patients with femoral neck fracture in total hip arthroplasty.
METHODS:From December 2015 to January 2018, 77 elderly women with femoral neck fractures undergoing total hip replacement were divided into four groups: group A, group B, group C, and group D. The group A (intravenous medication group) included 21 patients with an average age of (77.10±7.02) years old. The patients in group A received 15 mg/kg TXA intravenously 5 minutes before skin incision and intraoperative infusion of saline into the joint cavity. The group B(local medication group) included 18 cases, with an average age of (73.83±6.56) years old. The patients in group B received saline intravenously 5 minutes before skin incision and intraoperative infusion of 3 g TXA into the joint cavity. The group C (combined medication group) included 19 cases, with an average age of (74.26±6.04) year old. The patients in group C received 15 mg/kg TXA intravenously before operation and intraoperative infusion of 1.5 g TXA into the joint cavity. The group D (control group) included 19 cases, with an average age of (76.69±9.27) years old. The patients in group D received saline intravenously 5 minutes before skin incision and intraoperative infusion of saline into the joint cavity. The postoperative wound drainage volume, hemoglobin value, and the total blood loss calculated according to the height and weight and the hematocrit (HCT) before and after operation were observed and compared.
RESULTS:In group A, the postoperative drainage was(111.91±35.02)ml; the change of hemoglobin was(26.86±12.99) g/L; and total blood loss was(628.60±306.78) ml. In group B, postoperative drainage was(108.89±36.61) ml; change of hemoglobin was(26.28±8.59) g/L; and the total blood loss was (584.41±250.86) ml. In group C, postoperative drainage was(102.63±47.36) ml; change of hemoglobin was (26.89±12.47) g/L; and total blood loss was(634.78±384.89) ml. In group D, postoperative drainage was(107.37±40.53) ml; change of hemoglobin was(40.95±12.48) g/L; and total blood loss was(1 005.24±483.37) ml. There were no significant differences among 4 groups in postoperative drainage volume (>0.05). The hemoglobin and total blood loss in group A, B, and C were less than those in the group D(<0.05), however, there were no significant differences among three groups(>0.05).
CONCLUSIONS:Application of TXA can effectively reduce blood loss during perioperative period of total hip arthroplasty for elderly women with femoral neck fracture. The best administration route and dosage should be further studied.
